206 related articles for article (PubMed ID: 21521749)
21. Ovarian dependence for pituitary tumorigenesis in D2 dopamine receptor-deficient mice.
Hentges ST; Low MJ
Endocrinology; 2002 Dec; 143(12):4536-43. PubMed ID: 12446580
[TBL] [Abstract][Full Text] [Related]
22. The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas.
Recouvreux MV; Camilletti MA; Rifkin DB; Díaz-Torga G
J Endocrinol; 2016 Mar; 228(3):R73-83. PubMed ID: 26698564
[TBL] [Abstract][Full Text] [Related]
23. [Effects of growth factors and estrogen on the proliferation and prolactin gene expression in anterior pituitary cells of rats].
Wu X; Zhang R; Di A; Shan H; Xu R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):331-7. PubMed ID: 12567429
[TBL] [Abstract][Full Text] [Related]
24. Each individual isoform of the dopamine D2 receptor protects from lactotroph hyperplasia.
Radl D; De Mei C; Chen E; Lee H; Borrelli E
Mol Endocrinol; 2013 Jun; 27(6):953-65. PubMed ID: 23608643
[TBL] [Abstract][Full Text] [Related]
25. The ancient Chinese formula Longdan Xiegan Tang improves antipsychotic-induced hyperprolactinemia by repairing the hypothalamic and pituitary TGF-β1 signaling in rats.
Ren L; Liu W; Wang C; Yang Y; Huang X; Wang C; Li Y
J Ethnopharmacol; 2020 May; 254():112572. PubMed ID: 31940455
[TBL] [Abstract][Full Text] [Related]
26. Estrogen inhibits D2S receptor-regulated Gi3 and Gs protein interactions to stimulate prolactin production and cell proliferation in lactotropic cells.
Sengupta A; Sarkar DK
J Endocrinol; 2012 Jul; 214(1):67-78. PubMed ID: 22573829
[TBL] [Abstract][Full Text] [Related]
27. Involvement of insulin-like growth factor-I for the regulation of prolactin synthesis by estrogen and postnatal proliferation of lactotrophs in the mouse anterior pituitary.
Saitoh Y; Hikake T; Hayashi S; Iguchi T; Sato T
Cell Tissue Res; 2010 Apr; 340(1):147-58. PubMed ID: 20198387
[TBL] [Abstract][Full Text] [Related]
28. Role of GPER in the anterior pituitary gland focusing on lactotroph function.
Camilletti MA; Abeledo-Machado A; Ferraris J; Pérez PA; Faraoni EY; Pisera D; Gutierrez S; Díaz-Torga G
J Endocrinol; 2019 Feb; 240(2):99-110. PubMed ID: 30400046
[TBL] [Abstract][Full Text] [Related]
29. TGFβ1 regulates prolactin secretion during postnatal development: gender differences.
Abeledo-Machado A; Pérez PA; Camilletti MA; Faraoni EY; Picech F; Petiti JP; Gutiérrez S; Diaz-Torga G
J Endocrinol; 2020 Jul; 246(1):29-39. PubMed ID: 32302971
[TBL] [Abstract][Full Text] [Related]
30. Activin-inhibitory action on lactotrophs is decreased in lactotroph hyperplasia.
Faraoni EY; Abeledo Machado AI; Pérez PA; Marcial López CA; Camilletti MA; Peña-Zanoni M; Rulli SB; Gutiérrez S; Díaz-Torga G
J Endocrinol; 2020 Feb; 244(2):415-429. PubMed ID: 32395971
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta 1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth.
Sarkar DK; Kim KH; Minami S
Mol Endocrinol; 1992 Nov; 6(11):1825-33. PubMed ID: 1480172
[TBL] [Abstract][Full Text] [Related]
32. Estrogen actions on lactotroph proliferation are independent of a paracrine interaction with other pituitary cell types: a study using lactotroph-enriched cells.
Ishida M; Takahashi W; Itoh S; Shimodaira S; Maeda S; Arita J
Endocrinology; 2007 Jul; 148(7):3131-9. PubMed ID: 17412817
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta 1 inhibits prolactin secretion and lactotropic cell proliferation in the pituitary of oestrogen-treated Fischer 344 rats.
Minami S; Sarkar DK
Neurochem Int; 1997; 30(4-5):499-506. PubMed ID: 9106266
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta and p27 expression in pituitary cells.
Qian X; Jin L; Grande JP; Lloyd RV
Endocrinology; 1996 Jul; 137(7):3051-60. PubMed ID: 8770931
[TBL] [Abstract][Full Text] [Related]
35. Assessment of lactotroph axis functionality in mice: longitudinal monitoring of PRL secretion by ultrasensitive-ELISA.
Guillou A; Romanò N; Steyn F; Abitbol K; Le Tissier P; Bonnefont X; Chen C; Mollard P; Martin AO
Endocrinology; 2015 May; 156(5):1924-30. PubMed ID: 25643154
[TBL] [Abstract][Full Text] [Related]
36. Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats.
Rung JP; Rung E; Johansson AM; Svensson K; Carlsson A; Carlsson ML
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):39-45. PubMed ID: 21533991
[TBL] [Abstract][Full Text] [Related]
37. Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture.
Ishida M; Mitsui T; Yamakawa K; Sugiyama N; Takahashi W; Shimura H; Endo T; Kobayashi T; Arita J
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1529-37. PubMed ID: 17925456
[TBL] [Abstract][Full Text] [Related]
38. Fetal Alcohol Exposure Reduces Dopamine Receptor D2 and Increases Pituitary Weight and Prolactin Production via Epigenetic Mechanisms.
Gangisetty O; Wynne O; Jabbar S; Nasello C; Sarkar DK
PLoS One; 2015; 10(10):e0140699. PubMed ID: 26509893
[TBL] [Abstract][Full Text] [Related]
39. Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary Tumors.
Mangili F; Giardino E; Treppiedi D; Barbieri AM; Catalano R; Locatelli M; Lania AG; Spada A; Arosio M; Mantovani G; Peverelli E
Neuroendocrinology; 2021; 111(6):568-579. PubMed ID: 32512568
[TBL] [Abstract][Full Text] [Related]
40. Participation of membrane progesterone receptor α in the inhibitory effect of progesterone on prolactin secretion.
Camilletti MA; Ferraris J; Abeledo-Machado A; Converse A; Faraoni EY; Pisera D; Gutierrez S; Thomas P; Díaz-Torga G
J Neuroendocrinol; 2018 Sep; 30(9):e12614. PubMed ID: 29869822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
